The prognostic value of CDX2 in colorectal cancer: a meta- analysis

被引：0
|
作者：
Yu, Hongbin [1 ]
Zhang, Heng [2 ]
Cao, Qixin [3 ]
Zhu, Wei [1 ]
机构：
[1] First Peoples Hosp Huzhou, Dept Gen Surg, Huzhou, Zhejiang, Peoples R China
[2] Cent Hosp Lishui, Dept Gen Surg, Lishui, Zhejiang, Peoples R China
[3] Huzhou Hosp Tradit Chinese Med, Dept Surg, Huzhou, Zhejiang, Peoples R China
来源：
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE | 2016年 / 9卷 / 08期
关键词：
CDX2; colorectal cancer; prognosis; meta-analysis; INTESTINAL DEVELOPMENT; POOR-PROGNOSIS; EXPRESSION; TRANSCRIPTION; CARCINOMA; PHENOTYPE; SURVIVAL; CELLS;
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Caudal-type homeodomain transcription factors 2 (CDX2) acts as an intestine-specific transcription factor is essential for intestinal differentiation and development, which shows a low expression in colorectal cancer tissues. However, the prognostic role of CDX2 in colorectal cancer remains controversial. Here, a meta-analysis of eight published studies containing 2547 patients was conducted to evaluate the prognostic value of CDX2 in colorectal cancer by calculating the hazard ratio (HR) and its 95% confidence interval (CI). The summary results revealed that the low expression of CDX2 was association with poor prognosis of OS (HR=1.99, 95% CI: 1.31-3.02) and DFS (HR=1.81, 95% CI: 1.08-3.05). Subgroup analysis showed decreased CDX2 was a significant prognostic marker in Asian patients (HR= 2.66, 95% CI: 1.38-5.13), but not in Caucasian (HR= 1.56, 95% CI: 0.94-2.59). This meta-analysis demonstrated that CDX2 could act as a significant biomarker in the prognosis of colorectal cancer.
引用
收藏
页码：15955 / 15960
页数：6
相关论文
共 50 条
  • [31] Prognostic significance of CDX2 immunoexpression in poorly differentiated clusters of colorectal carcinoma
    Luca Reggiani Bonetti
    Simona Lionti
    Enrica Vitarelli
    Valeria Barresi
    Virchows Archiv, 2017, 471 : 731 - 741
  • [32] The homeobox gene CDX2 in colorectal carcinoma:: a genetic analysis
    Sivagnanasundaram, S
    Islam, I
    Talbot, I
    Drummond, F
    Walters, JRF
    Edwards, YH
    BRITISH JOURNAL OF CANCER, 2001, 84 (02) : 218 - 225
  • [33] Prognostic significance of CDX2 immunoexpression in poorly differentiated clusters of colorectal carcinoma
    Bonetti, Luca Reggiani
    Lionti, Simona
    Vitarelli, Enrica
    Barresi, Valeria
    VIRCHOWS ARCHIV, 2017, 471 (06) : 731 - 741
  • [34] CDX2 as a prognostic biomarker in stage II and stage III mismatch repair deficient colorectal cancer
    Ryan, E.
    Khaw, Y. L.
    Creavin, B.
    Geraghty, R.
    Gibbons, D.
    Sheahan, K.
    O'Connell, P. R.
    Winter, D. C.
    BRITISH JOURNAL OF SURGERY, 2017, 104 : 44 - 44
  • [35] The homeobox gene CDX2 in colorectal carcinoma: a genetic analysis
    S Sivagnanasundaram
    I Islam
    I Talbot
    F Drummond
    J R F Walters
    Y H Edwards
    British Journal of Cancer, 2001, 84 : 218 - 225
  • [36] Prognostic significance of MUC2, CDX2 and SOX2 in stage II colorectal cancer patients
    Ribeirinho-Soares, Sara
    Padua, Diana
    Amaral, Ana Luisa
    Valentini, Elvia
    Azevedo, Daniela
    Marques, Cristiana
    Barros, Rita
    Macedo, Filipa
    Mesquita, Patricia
    Almeida, Raquel
    BMC CANCER, 2021, 21 (01)
  • [37] Prognostic significance of MUC2, CDX2 and SOX2 in stage II colorectal cancer patients
    Sara Ribeirinho-Soares
    Diana Pádua
    Ana Luísa Amaral
    Elvia Valentini
    Daniela Azevedo
    Cristiana Marques
    Rita Barros
    Filipa Macedo
    Patrícia Mesquita
    Raquel Almeida
    BMC Cancer, 21
  • [38] CDX2 prognostic value in stage II/III resected colon cancer is related to CMS classification
    Pilati, C.
    Taieb, J.
    Balogoun, R.
    Marisa, L.
    de Reynies, A.
    Laurent-Puig, P.
    ANNALS OF ONCOLOGY, 2017, 28 (05) : 1032 - 1035
  • [39] The value of CDX2 and cytokeratins 7 and 20 expression in identifying colorectal metastases
    Jouini, R.
    Koubaa, W.
    Abdessayed, N.
    Msakni, I.
    Salah, M. Bel Haj
    Bouhafa, A.
    Khayat, O.
    Labbene, N.
    Ben Brahim, E.
    Debbiche, A. Chadli
    VIRCHOWS ARCHIV, 2013, 463 (02) : 210 - 210
  • [40] Relationship of CDX2 Loss with Molecular Features and Prognosis in Colorectal Cancer
    Baba, Yoshifumi
    Nosho, Katsuhiko
    Shima, Kaori
    Freed, Ellen
    Irahara, Natsumi
    Philips, Juliet
    Meyerhardt, Jeffrey A.
    Hornick, Jason L.
    Shivdasani, Ramesh A.
    Fuchs, Charles S.
    Ogino, Shuji
    CLINICAL CANCER RESEARCH, 2009, 15 (14) : 4665 - 4673
12345